Furthermore, an independent mouse cohort analyzed at a fixed time point (day 21 after tumor initiation) showed that five out of six mice in the DCP-IL-12/FLT3L group had no evidence of macroscopic tumors, whereas at least 50% of the mice had tumors in the other groups (Extended Data Fig. 9b). The gene discussed is ACE; the disease is neoplasm.